SIRT1 and diabetes mellitus: In HF mice without diabetes, dapagliflozin, an inhibitor of sodium-glucose-linked transporter 2, decreased EndMT brought on by ISO via deacetylating and breaking down NICD by SIRT1 (Wang W. et al., 2023).